Kimford Meador
Director of the Epilepsy Monitoring Unit · Stanford Health Care
Credentials: · · · · · ·
History
- Present
- Present
- Present
- 1984–1985
Epilepsy
1983–1984
1979–1983- 1974–1977
University of Virgina School of Medicine (1977) VA
- 1972–1976
Research
Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory
Epilepsia · 1998 · 624 citations
The Lancet Neurology · 2013 · First of 13 authors · Corresponding · 542 citations
Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs
New England Journal of Medicine · 2009 · First of 13 authors · Corresponding · 516 citations
- PP
63 papers
- JF
27 papers
27 papers
26 papers
25 papers · 3 as a fellow
- JS
22 papers
21 papers
20 papers
Grants
- 2024–2026
Vinpocetine Mediation of Prior Fetal Alcohol Exposure
National Institute on Alcohol Abuse and Alcoholism · R61
Contact PI · $564.1K · Stanford University
- 2000–2024
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $27.7M · Stanford University
- 2011–2018
Emory Clinical Research Site for NEXT
National Institute of Neurological Disorders and Stroke · U10
Contact PI · $288.8K · Emory University
- 2000–2012
Neurodevelopmental Effects of Antiepileptic Drugs II
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $12M · Emory University
Clinical trials
- 2024–2026
Neurodevelopmental Effects of Antiseizure Medications (NEAM) - UG3 Phase
Principal investigator · Withdrawn
Stanford University
- 2021–2023
Perampanel Titration and Cognitive Effects
Principal investigator · Terminated · Phase 4
Kimford Jay Meador
- 2016–2018
Principal investigator · Completed · Phase 4
Stanford University
- 2014–2015
Methylphenidate Treatment of Attention Deficits in Epilepsy
Principal investigator · Completed · Phase 4
Kimford Jay Meador